A platform built for the gynecologic oncology community

Oncology Out Loud brings clinicians together for candid, unbranded, peer-to-peer discussion of the questions shaping gynecologic cancer care. Unlike generalist insights agencies spanning the full oncology spectrum, we focus exclusively on gynecologic oncology. For us, it is our entire world.

Mission

Oncology Out Loud exists so the teams developing gynecologic cancer therapies understand how this care actually happens.

Oncology Out Loud exists so the teams developing gynecologic cancer therapies understand how this care actually happens.

We convene the clinicians who treat these cancers, academic and community alike, for candid, unbranded exchange that turns frontline experience into shared understanding.

Company Story

Why OOL was founded

After years inside gynecologic oncology drug development and commercialization, three problems kept surfacing. Insights agencies recruited the same familiar faces, many with little hands-on involvement in managing these cancers. Discussion formats were predictable and stale. And reports recapped what was said without explaining why it mattered.

Oncology Out Loud was built the other way around. Our connections run deep among the community clinicians who actually manage these cancers, alongside an established academic network. Our formats are built for genuine peer discussion. And our de-identified reporting explains what it means, not just what was said.

Leadership

Deep industry experience, vetted clinician network

Henry Haringsma, Founder and Managing Partner of Oncology Out Loud

Henry Haringsma

Managing Partner

Over a decade in gynecologic oncology, from translational research through commercialization, with launch experience across ovarian, endometrial, and cervical cancers.

Prior industry experience

Third-party programming

KOL engagement strategy

Advisory boards

Regional marketing

Medical affairs

Clinical development

Strategic Positioning

OOL operates at the intersection of real-world practice, clinical innovation, and industry context

Real-world practice

Programs are grounded in how gynecologic cancer care is actually delivered, across academic centers, community practices, and care teams.

Clinical innovation

Fluency in the evolving treatment landscape, from mechanism and trial design to what new data means at the point of care.

Industry context

Working knowledge of how industry teams operate, so findings are compliantly reported in terms that are useful rather than generic.

Get to know how Oncology Out Loud works

Unbranded, chair-led, independently executed. Clinicians can join the network; industry partners can learn how our programs run.

Get to know how Oncology Out Loud works

Unbranded, chair-led, independently executed. Clinicians can join the network; industry partners can learn how our programs run.

Get to know how Oncology Out Loud works

Unbranded, chair-led, independently executed. Clinicians can join the network; industry partners can learn how our programs run.